AKT1 E17K mutant phosphorylates BAD

Stable Identifier
R-HSA-2399941
Type
Reaction [transition]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
AKT1 E17K gain-of-function mutant phosphorylates BAD (Guo et al. 2010). AKT-mediated BAD phosphorylation inactivates BAD, thereby preventing BAD-mediated apoptosis (Del Peso et al. 1997).
Literature References
PubMed ID Title Journal Year
20440266 Oncogenic E17K mutation in the pleckstrin homology domain of AKT1 promotes v-Abl-mediated pre-B-cell transformation and survival of Pim-deficient cells

Wang, S, Guo, G, Wang, Z, Wang, G, Chen, JL, Chen, Y, Chen, Y, Rothman, PB, Qiu, X

Oncogene 2010
9381178 Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

Page, CP, Nunez, G, Gonzalez-Garcia, M, Herrera, R, del Peso, L

Science 1997
Participants
Participates
Catalyst Activity

protein serine/threonine kinase activity of p-T308,S473-AKT1 E17K [cytosol]

Normal reaction
Functional status

Gain of function of p-T308,S473-AKT1 E17K [cytosol]

Status
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Authored
Reviewed
Created
Cite Us!